Uranium’s contribution to society extends beyond power generation into healthcare. The decay of uranium isotopes and related processes are used to create radioisotopes essential in medical diagnostics and treatments. One of the most widely used isotopes, Technetium-99m, is employed in more than 30 million procedures each year to diagnose conditions such as cancer, heart disease, and bone disorders.

​

Another isotope, Cobalt-60, produced from uranium in reactors, plays a vital role in radiotherapy for cancer treatment. It provides targeted radiation used to shrink or destroy tumours, improving outcomes for patients around the world. In many healthcare systems, nuclear medicine is considered essential, and uranium-derived isotopes are integral to its functioning.

​

The use of uranium in medicine is not limited to treatment but also extends to sterilisation of medical equipment and laboratory research. Radioisotopes derived from uranium help ensure the safety of instruments used in surgery and diagnostics.

​

Globally, the healthcare applications of uranium show its importance beyond the energy sector. While nuclear medicine requires strict safety protocols, its benefits in extending life expectancy and improving health outcomes are widely recognised. The demand for medical isotopes continues to grow with aging populations and expanded access to advanced healthcare in developing nations.

​

In this way, uranium demonstrates a dual role: contributing to energy systems and playing a part in improving global health. Its impact is therefore both technological and humanitarian, underscoring the breadth of its applications.